Literature DB >> 16873560

Best practice in primary care pathology: review 3.

W S A Smellie1, J Forth, D Bareford, P Twomey, M J Galloway, E C M Logan, S R S Smart, T M Reynolds, C Waine.   

Abstract

This best practice review examines four series of common primary care questions in laboratory medicine: (i) "minor" blood platelet count and haemoglobin abnormalities; (ii) diagnosis and monitoring of anaemia caused by iron deficiency; (iii) secondary hyperlipidaemia and hypertriglyceridaemia; and (iv) glycated haemoglobin and microalbumin use in diabetes. The review is presented in question-answer format, referenced for each question series. The recommendations represent a précis of guidance found using a standardised literature search of national and international guidance notes, consensus statements, health policy documents and evidence-based medicine reviews, supplemented by Medline Embase searches to identify relevant primary research documents. They are not standards, but form a guide to be set in the clinical context. Most of the recommendations are based on consensus rather than evidence. They will be updated periodically to take account of new information.

Entities:  

Mesh:

Year:  2006        PMID: 16873560      PMCID: PMC1860461          DOI: 10.1136/jcp.200X.033944

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  76 in total

1.  Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

Authors:  J E Portielje; R G Westendorp; H C Kluin-Nelemans; A Brand
Journal:  Blood       Date:  2001-05-01       Impact factor: 22.113

2.  Evidence for a common, saturable, triglyceride removal mechanism for chylomicrons and very low density lipoproteins in man.

Authors:  J D Brunzell; W R Hazzard; D Porte; E L Bierman
Journal:  J Clin Invest       Date:  1973-07       Impact factor: 14.808

3.  Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia.

Authors:  S C Howard; A Gajjar; R C Ribeiro; G K Rivera; J E Rubnitz; J T Sandlund; P L Harrison; A de Armendi; G V Dahl; C H Pui
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

4.  Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.

Authors:  S Cortelazzo; G Finazzi; M Ruggeri; O Vestri; M Galli; F Rodeghiero; T Barbui
Journal:  N Engl J Med       Date:  1995-04-27       Impact factor: 91.245

Review 5.  Apparent polycythaemia.

Authors:  T C Pearson
Journal:  Blood Rev       Date:  1991-12       Impact factor: 8.250

6.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

7.  Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in Britain.

Authors:  J I Mann; B Lewis; J Shepherd; A F Winder; S Fenster; L Rose; B Morgan
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-18

8.  An observational study of severe hypertriglyceridemia, hypertriglyceridemic acute pancreatitis, and failure of triglyceride-lowering therapy when estrogens are given to women with and without familial hypertriglyceridemia.

Authors:  Naila M Goldenberg; Ping Wang; Charles J Glueck
Journal:  Clin Chim Acta       Date:  2003-06       Impact factor: 3.786

9.  Fetal thrombocytopenia and its relation to maternal thrombocytopenia.

Authors:  R F Burrows; J G Kelton
Journal:  N Engl J Med       Date:  1993-11-11       Impact factor: 91.245

10.  Effect of intensive diabetes management on macrovascular events and risk factors in the Diabetes Control and Complications Trial.

Authors: 
Journal:  Am J Cardiol       Date:  1995-05-01       Impact factor: 2.778

View more
  13 in total

Review 1.  Best practice in primary care pathology: review 6.

Authors:  W S A Smellie; J Forth; J J Coleman; W Irvine; P C Dore; G Handley; D G Williams; P J Galloway; K G Kerr; R Herriot; G P Spickett; T M Reynolds
Journal:  J Clin Pathol       Date:  2006-07-05       Impact factor: 3.411

Review 2.  Best practice in primary care pathology: review 5.

Authors:  W S A Smellie; J Forth; S Ryder; M J Galloway; A C Wood; I D Watson
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

Review 3.  Best practice in primary care pathology: review 8.

Authors:  W S A Smellie; K K Hampton; R Bowley; R Bowlees; S C Martin; N Shaw; J Hoffman; J P Ng; S M Mackenzie; C van Heyningen
Journal:  J Clin Pathol       Date:  2006-12-15       Impact factor: 3.411

Review 4.  Best practice in primary care pathology: review 4.

Authors:  W S A Smellie; J Forth; S Sundar; E Kalu; C A M McNulty; E Sherriff; I D Watson; C Croucher; T M Reynolds; P J Carey
Journal:  J Clin Pathol       Date:  2006-05-19       Impact factor: 3.411

Review 5.  Best practice in primary care pathology: review 9.

Authors:  W S A Smellie; N Shaw; R Bowlees; A Taylor; R Howell-Jones; C A M McNulty
Journal:  J Clin Pathol       Date:  2007-01-26       Impact factor: 3.411

Review 6.  Glycated haemoglobin (HbA1c) monitoring.

Authors:  Timothy M Reynolds; W Stuart A Smellie; Patrick J Twomey
Journal:  BMJ       Date:  2006-09-16

Review 7.  Best practice in primary care pathology: review 7.

Authors:  W S A Smellie; J Forth; S R S Smart; M J Galloway; W Irving; D Bareford; P O Collinson; K G Kerr; G Summerfield; P J Carey; Rubin Minhas
Journal:  J Clin Pathol       Date:  2006-10-17       Impact factor: 3.411

8.  Investigating iron status in microcytic anaemia.

Authors:  Michael J Galloway; W Stuart A Smellie
Journal:  BMJ       Date:  2006-10-14

Review 9.  Best practice in primary care pathology: review 10.

Authors:  W S A Smellie; N Shaw; R Bowley; M F Stewart; A M Kelly; P J Twomey; P R Chadwick; J B Houghton; J P Ng; A J McCulloch
Journal:  J Clin Pathol       Date:  2007-05-11       Impact factor: 3.411

10.  Routine OGTT screening for CFRD - no thanks.

Authors:  Martin Walshaw
Journal:  J R Soc Med       Date:  2009-07       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.